Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
American Journal of Blood Research|March 21, 2012
The ubiquitin-proteasomal system is critical for multiple myeloma: implications in drug discoveryBiyin Cao, Xinliang MaoCurrent Pharmaceutical Design|November 16, 2012
Dissecting bortezomib: development, application, adverse effects and future directionBiyin Cao, Jie Li, Xinliang MaoCurrent Pharmaceutical Design|September 5, 2013
The mTOR signaling pathway is an emerging therapeutic target in multiple myelomaJie Li, Jingyu Zhu, Biyin Cao, et al.Anti-Cancer Drugs|May 28, 2013
The antidepressant amitriptyline shows potent therapeutic activity against multiple myelomaZubin Zhang, Xiaolin Du, Changzhen Zhao, et al.Oncotarget|September 24, 2016
Interferon-stimulated gene 15 induces cancer cell death by suppressing the NF-κB signaling pathwayHongwu Mao, Man Wang, Biyin Cao, et al.Anti-Cancer Drugs|March 17, 2017
Nitroxoline shows antimyeloma activity by targeting the TRIM25/p53 axleHongwu Mao, Yanyun Du, Zubin Zhang, et al.European Journal of Haematology|September 17, 2013
Cyproheptadine-induced myeloma cell apoptosis is associated with inhibition of the PI3K/AKT signalingJie Li, Biyin Cao, Shunye Zhou, et al.Cell Communication and Signaling : CCS|February 25, 2021
Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosisTong Sun, Yujia Xu, Zhuan Xu, et al.Molecular Biosystems|December 17, 2013
Theoretical studies on beta and delta isoform-specific binding mechanisms of phosphoinositide 3-kinase inhibitorsJingyu Zhu, Peichen Pan, Youyong Li, et al.Journal of Biochemical and Molecular Toxicology|March 12, 2014
Natural pesticide dihydrorotenone arrests human plasma cancer cells at the G0/G1 phase of the cell cycleXin Xu, Jieyu Zhang, Kunkun Han, et al.Pageof 5